Skip to content
naulon

Not checkedNot checked for notices yet.

Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence?

Mario C Raviglione, Sudhir Kumar, Gianvincenzo Zuccotti and 10 more

BMJ Global Health · 2022

doi:10.1136/bmjgh-2021-008386 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Two years after the start of the COVID-19 pandemic, key questions about the emergence of its aetiological agent (SARS-CoV-2) remain a matter of considerable debate. Identifying when SARS-CoV-2 began spreading among people is one of those questions. Although the current canonically accepted timeline hypothesises viral emergence in Wuhan, China, in November or December 2019, a growing body of diverse studies provides evidence that the virus may have been spreading worldwide weeks, or even months, prior to that time. However, the hypothesis of earlier SARS-CoV-2 circulation is often dismissed with prejudicial scepticism and experimental studies pointing to early origins are frequently and speculatively attributed to false-positive tests. In this paper, we critically review current evidence that SARS-CoV-2 had been circulating prior to December of 2019, and emphasise how, despite some scientific limitations, this hypothesis should no longer be ignored and considered sufficient to warrant further larger-scale studies to determine its veracity.

Abstract licence: CC BY-NC

References51

  1. 5.
  2. 8.
  3. 11.
  4. 13.
  5. 14.
  6. 16.
  7. 24.
  8. 31.

32 more references, whose wording the paper’s licence keeps private.

All 51 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.